-
COVID ‘FLiRT’ Variants Are Spreading–Here’s What to Know -
GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall -
IgA Antibodies Appear to Protect Unvaccinated Against COVID-19: Study -
Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron -
Professor of Medicine Says Data Does Not Show Occurrence of Antibody-Dependant Enhancement -
UK-wide Antibody Testing Programme to Be Launched for COVID-19-Positive People -
NTD Evening News Full Broadcast (Aug. 20) -
BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study -
Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection -
Elderly Show Similar Antibody Response to 1st Dose of AstraZeneca, Pfizer COVID-19 Shots: UK Study -
Get Used to Annual Revaccination Against COVID-19, Boris Johnson Says -
UK Identifies 2 More COVID-19 Variants With Vaccine-Resistant Mutation -
Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections -
FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance -
More Test Positive in Expanded New York Antibody Testing -
Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci